Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Donato

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|November 20, 2016
Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: a real-life strategyMaria Francesca Donato, Cristina Morelli, Renato Romagnoli, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 17, 2021
Cost analysis of a long-term randomized controlled study in biliary duct-to-duct anastomotic stricture after liver transplantationPaolo Cantù, Giulio Santi, Roberto Rosa, et al.
Hepatology (Baltimore, Md.)|September 21, 2011
Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4Stella De Nicola, Alessio Aghemo, Maria Grazia Rumi, et al.
Journal of Hepatology|August 23, 2015
Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver diseaseValeria Grancini, Maddalena Trombetta, Maria Elena Lunati, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 28, 2023
Reproducibility and accuracy of a pocket-size ultrasound device in assessing liver steatosisAndrea Costantino, Alessandra Piagnani, Riccardo Caccia, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 16, 2019
High prevalence of early atherosclerotic and cardiac damage in patients undergoing liver transplantation: Preliminary resultsGiuseppina Pisano, Maria Francesca Donato, Dario Consonni, et al.
Journal of Hepatology|December 17, 2008
Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantationStefania Varchetta, Barbara Oliviero, M Francesca Donato, et al.
Transplantation|September 14, 2019
Experience With Early Sorafenib Treatment With mTOR Inhibitors in Hepatocellular Carcinoma Recurring After Liver TransplantationFederica Invernizzi, Massimo Iavarone, Claudio Zavaglia, et al.
Annals of Hepatology|April 7, 2012
Treatment of recurrent genotype 4 hepatitis C after liver transplantation: early virological response is predictive of sustained virological response. An AISF RECOLT-C group studyFrancesca Romana Ponziani, Alessandro Milani, Antonio Gasbarrini, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 10, 2015
Recipient female gender is a risk factor for graft loss after liver transplantation for chronic hepatitis C: Evidence from the prospective Liver Match cohortLuca Saverio Belli, Renato Romagnoli, Alessandra Nardi, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Liver International : Official Journal of the International Association for the Study of the Liver|November 20, 2016
Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: a real-life strategyMaria Francesca Donato, Cristina Morelli, Renato Romagnoli, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 17, 2021
Cost analysis of a long-term randomized controlled study in biliary duct-to-duct anastomotic stricture after liver transplantationPaolo Cantù, Giulio Santi, Roberto Rosa, et al.
Hepatology (Baltimore, Md.)|September 21, 2011
Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4Stella De Nicola, Alessio Aghemo, Maria Grazia Rumi, et al.
Journal of Hepatology|August 23, 2015
Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver diseaseValeria Grancini, Maddalena Trombetta, Maria Elena Lunati, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 28, 2023
Reproducibility and accuracy of a pocket-size ultrasound device in assessing liver steatosisAndrea Costantino, Alessandra Piagnani, Riccardo Caccia, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 16, 2019
High prevalence of early atherosclerotic and cardiac damage in patients undergoing liver transplantation: Preliminary resultsGiuseppina Pisano, Maria Francesca Donato, Dario Consonni, et al.
Journal of Hepatology|December 17, 2008
Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantationStefania Varchetta, Barbara Oliviero, M Francesca Donato, et al.
Transplantation|September 14, 2019
Experience With Early Sorafenib Treatment With mTOR Inhibitors in Hepatocellular Carcinoma Recurring After Liver TransplantationFederica Invernizzi, Massimo Iavarone, Claudio Zavaglia, et al.
Annals of Hepatology|April 7, 2012
Treatment of recurrent genotype 4 hepatitis C after liver transplantation: early virological response is predictive of sustained virological response. An AISF RECOLT-C group studyFrancesca Romana Ponziani, Alessandro Milani, Antonio Gasbarrini, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 10, 2015
Recipient female gender is a risk factor for graft loss after liver transplantation for chronic hepatitis C: Evidence from the prospective Liver Match cohortLuca Saverio Belli, Renato Romagnoli, Alessandra Nardi, et al.
Pageof 9